Financial Incentives Up Teen Glucose Monitoring Adherence

Share this content:
Financial Incentives Up Teen Glucose Monitoring Adherence
Financial Incentives Up Teen Glucose Monitoring Adherence

TUESDAY, Oct. 24, 2017 (HealthDay News) -- Financial incentives can improve adherence to glucose monitoring but not glycemic control among adolescents with type 1 diabetes, according to a study published online Oct. 23 in JAMA Pediatrics.

Charlene A. Wong, M.D., M.S.H.P., from Duke University in Durham, North Carolina, and colleagues randomized 90 participants (aged 14 to 20 years) with suboptimally controlled type 1 diabetes to the intervention or control arm (45 in each). The three-month intervention consisted of a $60 monthly incentive in a virtual account, with $2 subtracted for each day of nonadherence to monitoring goals. The intervention was discontinued during a three-month follow-up period.

The researchers found that in the incentive period, the intervention group had significantly greater adherence to glucose monitoring goals (50 versus 18.9 percent; adjusted difference, 27.2 percent [95 percent confidence interval, 9.5 to 45 percent; P = 0.003]), but adherence was not significantly greater in the follow-up period (15.3 versus 8.7 percent; adjusted difference, 3.9 percent [95 percent confidence interval, −2 to 9.9 percent; P = 0.2). There was no significant between-group difference in the change in hemoglobin A1c at three months (adjusted difference, −0.08 percent [95 percent confidence interval, −0.69 to 0.54 percent; P = 0.8]) or six months (adjusted difference, 0.03 percent [95 percent confidence interval, −0.55 to 0.6 percent; P = 0.93]).

"Among adolescents and young adults with type 1 diabetes, daily financial incentives improved glucose monitoring adherence during the incentive period but did not significantly improve glycemic control," the authors write.

One author is a principal at Catalyst Health, a technology and behavior change consulting firm.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Dozens of Medical Groups Join Forces to Improve Diagnoses

Dozens of Medical Groups Join Forces to Improve ...

Diagnostic error is the most common cause of medical errors that patients report

HbA1c Variability Is a Strong Predictor of Mortality in T2DM

HbA1c Variability Is a Strong Predictor of Mortality ...

HbA1c variability is a powerful, independent measure, regardless of how it is measured

Pediatric End-Stage Liver Disease Score Underestimates Mortality

Pediatric End-Stage Liver Disease Score Underestimates Mortality

Actual probability of death for patients on liver transplant wait list underestimated by up to 17%

is free, fast, and customized just for you!




Already a member?

Sign In Now »